Topic Editors

2. Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Vila Real, Portugal

2. Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
Prostate Cancer: Symptoms, Diagnosis & Treatment—3rd Edition
Topic Information
Dear Colleagues,
This Topic is a continuation of the previous successful Topics "Prostate Cancer: Symptoms, Diagnosis and Treatment" (https://www.mdpi.com/topics/prostate_Cancer; https://www.mdpi.com/topics/prostate_Cancer2). The prostate is the largest accessory gland of the male reproductive tract. Together with seminal vesicles and bulbourethral glands, the prostate is responsible for producing an alkaline fluid that forms part of the seminal fluid. The prostates of men over 40 years of age are commonly affected by several pathologies, such as benign prostate hyperplasia and cancer. Prostate cancer is one of the most common cancers among the male population worldwide. According to the World Health Organization (WHO), in 2020, prostate cancer affected approximately 1.41 million men worldwide. Despite significant treatment improvements having been achieved with the advent of targeted and immune-checkpoint-inhibitor-based therapies, cancer remains a primary causes of death worldwide. Therefore, this Topic will consider articles on all types of research on prostate cancer, including in vitro and in vivo approaches. Research on the impacts of the tumor macroenvironment (microbiota, diet, physical exercise) on tumor biology, as well as review studies, is also welcome. We invite scientists to publish their excellent work in one of the following journals: Cancers, Diagnostics or Medicina.
Dr. Ana Faustino
Prof. Dr. Lúcio Lara Santos
Prof. Dr. Paula Oliveira
Topic Editors
Keywords
- cancer biology
- in vitro
- in vivo
- resistance
- treatment
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
---|---|---|---|---|---|---|
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 | Submit |
![]()
Diagnostics
|
3.0 | 4.7 | 2011 | 20.3 Days | CHF 2600 | Submit |
![]()
Medicina
|
2.4 | 3.3 | 1920 | 17.1 Days | CHF 2200 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
Related Topics
- Prostate Cancer: Symptoms, Diagnosis & Treatment (25 articles)
- Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume (16 articles)